Possible novel therapy for malignant gliomas with secretable trimeric TRAIL

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  Jeong, Moonsup ^a,b   Kwon, Yong Sam ^a   Park, Soon Hye ^a   Kim, Chae Young ^a   Jeun, Sin Soo ^b   Song, Kang Won ^c   Ko, Yong ^c   Robbins, Paul D ^d   Billiar, Timothy R ^d   Kim, Byong Moon ^a   Seol, Dai Wu ^d,e  

^a Dong A Pharmaceutical Company   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Hanyang University Medical Center   (South Korea)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e Gachon University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; CARMUSTINE; SECRETABLE TRIMERIC TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; FEMALE; GENE THERAPY; GLIOBLASTOMA; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; REPEATED DRUG DOSE; TUMOR GROWTH; VIRAL GENE DELIVERY SYSTEM; WEIGHT REDUCTION;

ADENOVIRIDAE; MUS; MUS MUSCULUS;

EID: 84887212386     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004545     Document Type: Article

References (20)

1. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, et al. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682.
2. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, et al. (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271: 12687-12690.
3. Cha SS, Kim MS, Choi YH, Sung BJ, Shin NK, et al. (1999) 2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity. Immunity 11: 253-261.
4. Hymowitz SG, Christinger HW, Fuh G, Ultsch M, O'Connell M, et al. (1999) Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell 4: 563-571.
5. Seol DW, Billiar TR (2000) Cysteine 230 modulates tumor necrosis factor-related apoptosis-inducing ligand activity. Cancer Res 60: 3152-3154.
6. Hymowitz SG, O'Connell MP, Ultsch MH, Hurst A, Totpal K, et al. (2000) A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL. Biochemistry 39: 633-640.
7. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, et al. (1997) The receptor for the cytotoxic ligand TRAIL. Science 276: 111-113.
8. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, et al. (1997) TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J 16: 5386-5397.
9. MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM, et al. (1997) Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J Biol Chem 272: 25417-25420.
10. Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, et al. (2000) FADD/ MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12: 599-609.
11. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, et al. (2000) Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12: 611-620.
12. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, et al. (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104: 155-162.
13. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, et al. (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157-163.
14. Kim Y, Seol DW (2003) TRAIL, a mighty apoptosis inducer. Mol Cells 15: 283-293.
15. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, et al. (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15: 1311-1333.
16. Lefranc F, Brotchi J, Kiss R (2005) Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23: 2411-2422.
17. Kim MH, Billiar TR, Seol DW (2004) The secretable form of trimeric TRAIL, a potent inducer of apoptosis. Biochem Biophys Res Commun 321: 930-935.
18. Denault JB, Leduc R (1996) Furin/PACE/SPC1: a convertase involved in exocytic and endocytic processing of precursor proteins. FEBS Lett 379: 113-116.
19. Kim CY, Jeong M, Mushiake H, Kim BM, Kim WB, et al. (2006) Cancer gene therapy using a novel secretable trimeric TRAIL. Gene Ther 13: 330-338.
20. Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML (1997) Construction of adenovirus vectors through Cre-lox recombination. J Virol 71: 1842-1849.